BioWorld

Oct. 5, 2006

Plexxikon Enters Roche Deal On B-Raf Inhibitors For $706M

Earlier this week, Plexxikon Inc.'s president Kathleen Sereda Glaub told BioWorld Today that the company was in "active partnering mode." (BioWorld Today) Read More

Genentech, CGI In Potential $500M Kinase-Focused Deal

Killing Bacterial Gang Of Four Can Divide, Conquer Biofilms

HGS Updates Pipeline, Unveils Albuferon Phase III HCV Plans

Capitalizing On Stock Boost, Acorda Raises $32M Privately

Clinic Roundup

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 10, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...